Institute of Cancer Research (ICR) and the Royal Marsden Hospital (RMH) - United Kingdom
The Radioisotope Physics Group (RIT) of the Institute of Cancer Research (ICR) and the Royal Marsden Hospital (RMH) has been involved at both a research and clinical level in molecular radiotherapy for over 20 years. A particular focus of the group during that time has been on quantitative molecular imaging and internal dosimetry, in which areas the group have international recognition.
The group is led by Dr Glenn Flux who is a chair or member of several national and international committees, including the European Association of Nuclear Medicine Dosimetry Committee. The group has published extensively on clinical applications of dosimetry and quantitative imaging and have been at the forefront of many areas, including 3D dosimetry [1], the determination of absorbed -dose effect relationships [2] and I-124 imaging in PET/CT [3]. The group have also studied uncertainty analysis in the specific context of dosimetry [4].
The group will primarily support Workpackage 2 (Quantitative imaging for MRT) and Workpackage 5 (Uncertainty analysis). In particular, the group will provide resources for a series of phantom image studies of radionuclides, will share their previous experience in these areas and will advise on the clinical relevance and potential applications of the research undertaken.
The experience of the group in clinical applications of dosimetry as well as with more fundamental aspects will complement the National Metrology Institutes in this programme.
For more information: Contact Vere Smyth
